TCL Archive Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer June 27, 2014
TCL Archive Venter Steps Down As Celera President; Moffitt, Puerto Rico Center Win NCI P20 Grant. January 25, 2002